(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, ...
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year ...
After Johnson & Johnson's consumer healthcare spinoff last year—and its subsequent reduction in holdings in the new ...
(Bloomberg) -- Johnson & Johnson and Kenvue Inc. were ordered to pay $45 million to the family of an Illinois woman who blamed the companies’ baby powders for giving her a fatal cancer in what ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
London: Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5 per cent stake in the company, about a year after the healthcare conglomerate spun off and listed its ...